Press Releases
iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
NASHUA, N.H., February 9, 2023 — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 14-16, 2023 in Snowbird, UT. Stacey…
iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI
Daniel Shea appointed as interim Chief Financial Officer William Keyes hired as Senior Vice President, US Commercial Sales, AI NASHUA, N.H. – January 23, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of Directors…
iCAD Announces Board of Directors Transition
Dana Brown named Executive Chair of the Board NASHUA, N.H. – January 11, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the appointment of Dana Brown as Executive Chair of the Board of Directors. Ms. Brown has been a…
iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar
Solis Mammography’s Chief Medical Officer Chirag Parghi, MD, to share clinical experience and real-world case studies demonstrating clinical value of ProFound AI NASHUA, N.H. – December 5, 2022 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Solis Mammography, the…
iCAD and Google Health Ink Strategic Development and Commercialization Agreement
Google Health AI and Cloud technology to be integrated into iCAD’s portfolio with potential to elevate performance and expand access to millions of women worldwide Agreement marks Google Health’s first partnership with a mammography AI vendor NASHUA, N.H. – November 28, 2022 – iCAD, Inc. (NASDAQ: ICAD), a…
Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection
Study affirms utility of ProFound AI’s Case Scores in improving cancer detection Company’s Breast AI Suite of deep-learning breast cancer detection, density assessment and risk evaluation tools showcased at largest medical imaging forum in the world NASHUA, N.H. – November 21, 2022 – iCAD, Inc. (NASDAQ: ICAD), a…
iCAD to Participate in the 13th Annual Craig-Hallum Alpha Select Conference
NASHUA, N.H. – November 15, 2022 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, Chief Executive Officer, will participate at the 13th Annual Craig-Hallum Alpha Select Conference on Thursday, November 17th. The conference will be held…
iCAD to Present at HLTH 2022 With Google
Google invites iCAD’s President and CEO, Stacey Stevens, to be a featured speaker in the Google Health Theater Room on Tuesday, November 15 NASHUA, N.H. – November 14, 2022 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced iCAD…
iCAD to Join Forces with Radiology Partners, the Nation’s Largest Radiology Practice
Strategic commercial agreement in development will leverage Radiology Partners’ clinical expertise, ability to scale and leadership position to drive nationwide adoption of iCAD’s Breast AI Suite NASHUA, N.H. – November 10, 2022 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions,…
iCAD Reports Financial Results for Third Quarter Ended September 30, 2022
Company implements corporate strategic realignment Partnership-based recurring revenue model anticipated to drive future growth Cost structure reduction to decrease expenses by over $3 million annually Company to host conference call and webcast today at 4:30 PM ET NASHUA, N.H. – November 10, 2022 – iCAD, Inc. (NASDAQ: ICAD), a global medical…